Skip to main content
Maya Guglin, MD, Cardiology, New Brunswick, NJ

Maya E Guglin MD

Adult Congenital Heart Disease, Heart Failure & Transplantation, Interventional Cardiology


Director, Heart Failure and Transplant/Assist Devices, University of South Florida

Join to View Full Profile
  • 10 Plum Street7th FloorNew Brunswick, NJ 08901

  • Phone+1 732-253-3699

  • Fax+1 732-253-3466

Dr. Guglin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Cooper Medical School of Rowan University/Cooper University Hospital
    Cooper Medical School of Rowan University/Cooper University HospitalFellowship, Cardiovascular Disease, 2000 - 2003
  • Columbia Saint Luke's Medical Center
    Columbia Saint Luke's Medical CenterResidency, Internal Medicine, 1997 - 2000
  • The Volgograd State Medical University
    The Volgograd State Medical UniversityClass of 1984

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2000 - 2027
  • IN State Medical License
    IN State Medical License 2019 - 2025
  • KY State Medical License
    KY State Medical License 2014 - 2020
  • FL State Medical License
    FL State Medical License 2006 - 2015
  • MI State Medical License
    MI State Medical License 2003 - 2007
  • OH State Medical License
    OH State Medical License 1999 - 2005
  • Advanced Heart Failure and Transplant Cardiology
    American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
  • Cardiovascular Disease
    American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR, Allscripts, 2012, 2014, 2016-2017
  • CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR (Complete), Allscripts, 2012, 2014, 2016-2017
  • CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • [Board 509] Chemotherapy-Induced Cardiomyopathy: Anthracyclines and Trastuzumab Require Different Approach to Monitoring and Prevention
    Maya Guglin, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/17/2019

Lectures

  • Noncompaction Cardiomyopathy: More than Just Trabeculations 
    2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019

Press Mentions

  • The Joint Commission Re-Certifies Robert Wood Johnson University Hospital Device Program
    The Joint Commission Re-Certifies Robert Wood Johnson University Hospital Device ProgramAugust 15th, 2025
  • ACC Survey Sheds Light on Unmet Workforce Needs in Advanced HF and Transplant Cardiology
    ACC Survey Sheds Light on Unmet Workforce Needs in Advanced HF and Transplant CardiologyApril 10th, 2025
  • Study Calls for Targeted Strategies for Managing Diabetic Cardiomyopathy Across Racial, Ethnic Groups
    Study Calls for Targeted Strategies for Managing Diabetic Cardiomyopathy Across Racial, Ethnic GroupsJuly 8th, 2024

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: